Ukr.Biochem.J. 2016; Volume 88, Special Issue, pp. 105-112


New thiopyrano[2,3-d][1,3]thiazole derivatives as potential antiviral agents

N. I. Zelisko, I. L. Demchuk, R. B. Lesyk*

Danylo Halytsky Lviv National Medical University, Ukraine;

A series of novel thiopyrano[2,3-d][1,3]thiazole derivatives were synthesized and evaluated for their antiviral activity in vitro within AACF NIAID programme. Compounds were studied towards Dengue Virus Type 2, Venezuelan Equine Encephalitis Virus, Respiratory Syncytial Virus, SARS Coronavirus, Rift Valley Fever Virus, Tacaribe Virus, Influenza Virus Types A and B. Among the tested thiopyrano[2,3-d][1,3]thiazoles, alkyl rel-(5R,5aR,11bS)-2,6-dioxo-3,5a,6,11b-tetrahydro-2Н,5H-chromeno[4’,3’:4,5]thiopyrano[2,3-d][1,3]thiazole-5-carboxylates 8 and 11 were found to be the most active and showed significant antiviral activity against Influenza Virus Types A H3N2 and H5N1.

Keywords: , ,


  1. Lesyk R, Zimenkovsky B, Atamanyuk D, Jensen F, Kiec-Kononowicz K, Gzella A. Anticancer thiopyrano[2,3-d][1,3]thiazol-2-ones with norbornane moiety. Synthesis, cytotoxicity, physico-chemical properties, and computational studies. Bioorg Med Chem. 2006 Aug 1;14(15):5230-40.  PubMed, CrossRef
  2. Atamanyuk D, Zimenkovsky B, Lesyk R. Synthesis and anticancer activity of novel thiopyrano[2,3-d]thiazole-based compounds containing norbornane moiety. J Sulf Chem. 2008; 29(2): 151-162.  CrossRef
  3. Zelisko N, Atamanyuk D, Vasylenko O, Grellier P, Lesyk R. Synthesis and antitrypanosomal activity of new 6,6,7-trisubstituted thiopyrano[2,3-d][1,3]thiazoles. Bioorg Med Chem Lett. 2012 Dec 1;22(23):7071-4.  PubMed, CrossRef
  4. Atamanyuk D, Zimenkovsky B, Atamanyuk V, Nektegayev I, Lesyk R. Synthesis and Biological Activity of New Thiopyrano[2,3-d]thiazoles Containing a Naphthoquinone Moiety. Sci Pharm. 2013 Jun;81(2):423-36.  PubMed, PubMedCentral, CrossRef
  5. Kryshchyshyn A, Atamanyuk D, Lesyk R. Fused Thiopyrano[2,3-d]thiazole Derivatives as Potential Anticancer Agents. Sci Pharm. 2012 Sep;80(3):509-29.  PubMed, PubMedCentral, CrossRef
  6. Lozynskyi AV, Kaminskyy DV, Romanchy­shyn KhB, Semenciv NG, Ogurtsov VV, Nektegayev IO, Lesyk RB. Screening of antioxidant and anti-inflammatory activities among thiopyrano[2,3-d]thiazoles.  Biopolym Cell. 2015; 31(2): 131-137. CrossRef
  7. Lozynskyi A, Zimenkovsky B, Nektegayev I, Lesyk R. Arylidene pyruvic acids motif in the synthesis of new thiopyrano[2,3-d]thiazoles as potential biologically active compounds.  Heterocycl Commun. 2015; 21(1): 55-59. CrossRef
  8. Al-Ansary GH, Ismail MA, Abou El Ella DA, Eid S, Abouzid KA. Molecular design and synthesis of HCV inhibitors based on thiazolone scaffold. Eur J Med Chem. 2013 Oct;68:19-32.  PubMed, CrossRef
  9. Talele TT, Arora P, Kulkarni SS, Patel MR, Singh S, Chudayeu M, Kaushik-Basu N. Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase. Bioorg Med Chem. 2010 Jul 1;18(13):4630-8.  PubMed, PubMedCentral, CrossRef
  10. Havrylyuk D, Zimenkovsky B, Vasylenko O, Lesyk R. Synthesis and anticancer and antiviral activities of new 2-pyrazoline-substituted 4-thiazolidinones. J Heterocyclic Chem. 2013; 50(S1): E55-E62. CrossRef
  11. Barreca ML, Iraci N, Manfroni G, Cecchetti V. Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development. Future Med Chem. 2011 Jun;3(8):1027-55.  PubMed, CrossRef
  12. Nitsche C, Schreier VN, Behnam MA, Kumar A, Bartenschlager R, Klein CD. Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture. J Med Chem. 2013 Nov 14;56(21):8389-403.  PubMed, CrossRef
  13. Jiang S, Tala SR, Lu H, Abo-Dya NE, Avan I, Gyanda K, Lu L, Katritzky AR, Debnath AK. Design, synthesis, and biological activity of novel 5-((arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 fusion inhibitors targeting gp41. J Med Chem. 2011 Jan 27;54(2):572-9.  PubMed, CrossRef
  14. Kowiel M, Zelisko N, Atamanyuk D. Lesyk R, Gzella AK. 2-[7-(3,5-Dibromo-2-hydroxyphenyl)-6-ethoxycarbonyl-2-oxo-5H-2,3,6,7-tetrahydrothiopyrano[2,3-d][1,3]thiazol-6-yl]acetic acid ethanol monosolvate.  Acta Crystallogr E. 2012; E68: 2721-2722.  CrossRef
  15. Zelisko N, Atamanyuk D, Vasylenko O, Bryhas A, Matiychuk V, Gzella A, Lesyk R. Crotonic, cynnamic, and propiolic acids motifs in the synthesis of thiopyrano[2,3-d][1,3]thiazoles via hetero-Diels-Alder reaction and related tadem processes.  Tetrahedron. 2014; 70(3): 720-729. CrossRef
  16. Zelisko N, Atamanyuk D, Ostapiuk Y, Bryhas A, Matiychuk V, Gzella A, Lesyk R. Synthesis of fused thiopyrano[2,3-d][1,3]thiazoles via hetero-Diels-Alder reaction related tandem and domino processes. Tetrahedron. 2015; 71(50): 9501-8. CrossRef
  17. Sidwell RW, Smee DF. In vitro and in vivo assay systems for study of influenza virus inhibitors. Antiviral Res. 2000 Oct;48(1):1-16.  PubMed, CrossRef
  18. Severson WE, Shindo N, Sosa M, Fletcher T 3rd, White EL, Ananthan S, Jonsson CB. Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library. J Biomol Screen. 2007 Feb;12(1):33-40.  PubMed, CrossRef
  19. Sidwell RW, Huffman JH. Use of disposable micro tissue culture plates for antiviral and interferon induction studies. Appl Microbiol. 1971 Nov;22(5):797-801.  PubMed, PubMedCentral

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.